Recently, the National Development and Reform Commission issued the “Measures for Examining the Prices of Pharmaceutical Products (Trial)†notice. Unlike previous surveys, the National Development and Reform Commission replaced the investigation of production costs with the ex-factory price survey, and also investigated the retail price of pharmaceuticals. An Bianguang Consulting Group pharmaceutical industry researcher Bian Chenguang expressed concern that after the investigation of the factory price, the company may be forced to raise the factory price.
The official website of the National Development and Reform Commission shows that the object of the ex-factory price survey for drugs is the domestic production or import of subpackaged drugs. The investigation content is the actual ex-factory price of the drug, and the investigation of the sales situation is based on independent sales, agency sales, commissioned processing, and other methods. Divide.
Unlike previous price surveys, the NDRC's price survey replaced the production cost survey with a factory price survey.
The industry speculated that this may be related to CCTV's investigation. A few days ago, CCTV reporters found that some of the commonly used drugs had a much higher bid price than the ex-factory price. There is also a drug with an intermediate profit of more than 6500% in the ex-factory price and retail price.
Yu Mingde, president of the Chinese Medicine (600056) Business Management Association, told the Daily Economic News reporter that there are difficulties in the investigation of the cost of medicines. The most transparent chemical preparations for the current price of drugs can be compared because they are produced by a number of companies. However, some exclusive and irreplaceable products make it difficult to find out the costs.
In the early morning light, he said with concern that after the ex-factory price survey, the spread between the final retail price and the ex-factory price may be limited to a certain extent, eliminating the middle high profit situation, but the result may be to force companies to raise the ex-factory price. It also entraps production companies in the "dark links" of the pharmaceutical industry.
According to Chen Guangguang, from the perspective of previous CCTV exposure, although the price difference between the ex-factory price and the retail price of pharmaceuticals was striking, the astonishing price difference did not remain in the pharmaceutical companies, but in agents, tenders, hospitals, doctors, etc. The distribution in the link, the company's profit is fixed.
According to the new methods announced by the National Development and Reform Commission, the situation that the difference between the middle profits is too large will be eliminated. If there is no corresponding subsidies in the middle of the dark link, there will be no way to operate. Ultimately, it will only allow the company to raise the factory price and make up for the profits. The loss of dark links. (Author: Huang Zhiwei)
The official website of the National Development and Reform Commission shows that the object of the ex-factory price survey for drugs is the domestic production or import of subpackaged drugs. The investigation content is the actual ex-factory price of the drug, and the investigation of the sales situation is based on independent sales, agency sales, commissioned processing, and other methods. Divide.
Unlike previous price surveys, the NDRC's price survey replaced the production cost survey with a factory price survey.
The industry speculated that this may be related to CCTV's investigation. A few days ago, CCTV reporters found that some of the commonly used drugs had a much higher bid price than the ex-factory price. There is also a drug with an intermediate profit of more than 6500% in the ex-factory price and retail price.
Yu Mingde, president of the Chinese Medicine (600056) Business Management Association, told the Daily Economic News reporter that there are difficulties in the investigation of the cost of medicines. The most transparent chemical preparations for the current price of drugs can be compared because they are produced by a number of companies. However, some exclusive and irreplaceable products make it difficult to find out the costs.
In the early morning light, he said with concern that after the ex-factory price survey, the spread between the final retail price and the ex-factory price may be limited to a certain extent, eliminating the middle high profit situation, but the result may be to force companies to raise the ex-factory price. It also entraps production companies in the "dark links" of the pharmaceutical industry.
According to Chen Guangguang, from the perspective of previous CCTV exposure, although the price difference between the ex-factory price and the retail price of pharmaceuticals was striking, the astonishing price difference did not remain in the pharmaceutical companies, but in agents, tenders, hospitals, doctors, etc. The distribution in the link, the company's profit is fixed.
According to the new methods announced by the National Development and Reform Commission, the situation that the difference between the middle profits is too large will be eliminated. If there is no corresponding subsidies in the middle of the dark link, there will be no way to operate. Ultimately, it will only allow the company to raise the factory price and make up for the profits. The loss of dark links. (Author: Huang Zhiwei)
The single dome LED series cold-light shadowless surgical lights of our factory, which are adopted LED bulbs as the light source, the OT lamp has owned the authentic cold illiminant effect, improved the characteristics of high color rendering, high gemcore, low vertifo, high equitability, low electromagnetic interference, long life span, LED bulb can be more than 50,000 hours, low power consumption etc, it is the new advanced products to instead of traditional shadowless operation lamps;
Single Dome Round Ot Lamp,Single Dome Operation Light,Single Dome Surgery Lamp,Single Dome Operating Lamp
Shandong Lewin Medical Equipment Co., Ltd. , https://www.operatinglight.nl